ReviewHematology/oncology clinics of North America2021

The Evolving Use of Phosphatidylinositol 3-Kinase Inhibitors for the Treatment of Chronic Lymphocytic Leukemia.

Benjamin L Lampson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.